BCL2L11 and cancer: Since the specific autophagy is of greater therapeutic interest than basal autophagy and because mitophagy is often upregulated in therapy-resistant cancer cells and is a requirement for cancer stem cells (CSCs) [29, 30], the Hsp70-Bim PPI may be a more attractive therapeutic target than the general autophagy-related PPIs.